DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Naloxone (Naloxone) - Confusional State - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Confusional State (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Naloxone where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Naloxone side effects in female

Reported by a pharmacist from Italy on 2012-02-28

Patient: female

Reactions: Confusional State, Bradykinesia, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Naloxone
    Dosage: strenght: 10 mg + 5 mg; daily dose: 2 posologic units
    Administration route: Oral
    Indication: Radiculopathy
    Start date: 2011-02-01
    End date: 2011-07-11

Zoloft
    Dosage: one posologic unit
    Administration route: Oral
    Indication: Depression
    Start date: 2011-02-01
    End date: 2011-07-11

Clonazepam
    Dosage: 15 anz
    Administration route: Oral
    Start date: 2006-01-17
    End date: 2011-07-11

Pramipexole Dihydrochloride
    Dosage: 0.54 mg
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2007-04-29
    End date: 2011-07-16

Topamax
    Dosage: one posologic unit
    Administration route: Oral
    Start date: 2011-02-01
    End date: 2011-07-11

Duloxetine Hydrochloride
    Dosage: 60 mg
    Administration route: Oral
    Start date: 2011-02-01
    End date: 2011-07-11

Other drugs received by patient: Coumadin; Nebivolol HCL; Levothyroxine Sodium; Furosemide; Esopral



Possible Naloxone side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-27

Patient: female

Reactions: Confusional State, Bradykinesia, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clonazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-01-17
    End date: 2011-07-11

Pramipexole Dihydrochloride
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2007-04-29
    End date: 2011-07-16

Duloxetine Hydrochloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-01
    End date: 2011-07-11

Zoloft
    Administration route: Oral
    Indication: Depression
    Start date: 2011-02-01
    End date: 2011-07-11

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-01
    End date: 2011-07-11

Naloxone
    Administration route: Oral
    Indication: Radiculopathy
    Start date: 2011-02-01
    End date: 2011-07-11

Other drugs received by patient: Coumadin; Nebivolol HCL; Furosemide; Levothyroxine Sodium; Esopral



Possible Naloxone side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-16

Patient: female

Reactions: Confusional State, Bradykinesia, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pramipexole Dihydrochloride
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2007-04-29
    End date: 2011-07-16

Naloxone
    Administration route: Oral
    Indication: Radiculopathy
    Start date: 2011-02-01
    End date: 2011-07-11

Duloxetine Hydrochloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-01
    End date: 2011-07-11

Clonazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-01-17
    End date: 2011-07-11

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-01
    End date: 2011-07-11

Zoloft
    Administration route: Oral
    Indication: Depression
    Start date: 2011-02-01
    End date: 2011-07-11

Other drugs received by patient: Levothyroxine Sodium; Furosemide; Esopral; Nebivolol HCL; Coumadin



Possible Naloxone side effects in female

Reported by a physician from Italy on 2012-02-09

Patient: female

Reactions: Confusional State, Bradykinesia, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-01
    End date: 2011-07-11

Naloxone
    Administration route: Oral
    Indication: Radiculopathy
    Start date: 2011-02-01
    End date: 2011-07-11

Clonazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-01-17
    End date: 2011-07-11

Zoloft
    Indication: Depression
    Start date: 2011-02-01
    End date: 2011-07-11

Pramipexole Dihydrochloride
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2007-04-29
    End date: 2011-07-16

Duloxetine Hydrochloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-02-01
    End date: 2011-07-11

Other drugs received by patient: Esomeprazole; Levothyroxine Sodium; Coumadin; Furosemide; Nebivolol HCL



Possible Naloxone side effects in female

Reported by a pharmacist from Italy on 2012-02-08

Patient: female

Reactions: Confusional State, Bradykinesia, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Naloxone
    Dosage: strenght: 10 mg + 5 mg; daily dose: 2 posologic units
    Administration route: Oral
    Indication: Radiculopathy
    Start date: 2011-02-01
    End date: 2011-07-11

Clonazepam
    Dosage: 15 anz
    Administration route: Oral
    Start date: 2006-01-17
    End date: 2011-07-11

Topamax
    Dosage: one posologic unit
    Administration route: Oral
    Start date: 2011-02-01
    End date: 2011-07-11

Duloxetine Hydrochloride
    Dosage: 60 mg
    Administration route: Oral
    Start date: 2011-02-01
    End date: 2011-07-11

Pramipexole Dihydrochloride
    Dosage: 0.54 mg
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2007-04-29
    End date: 2011-07-16

Zoloft
    Dosage: one posologic unit
    Administration route: Oral
    Indication: Depression
    Start date: 2011-02-01
    End date: 2011-07-11

Other drugs received by patient: Coumadin; Esopral; Furosemide; Nebivolol HCL; Levothyroxine Sodium

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017